Journal
MAYO CLINIC PROCEEDINGS
Volume 91, Issue 12, Pages 1778-1810Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.mayocp.2016.08.022
Keywords
-
Categories
Funding
- Boston Scientific
- Medtronic
Ask authors/readers for more resources
As the most common sustained arrhythmia in adults, atrial fibrillation (AF) is an established and growing epidemic. To provide optimal patient care, it is important for clinicians to be aware of AF's epidemiological trends, methods of risk reduction, and the various available treatment modalities. Our understanding of AF's pathophysiology has advanced, and with this new understanding has come advancements in prevention strategies as well as pharmacological and nonpharmacological treatment options. Following PubMed and MEDLINE searches for AF risk factors, epidemiology, and therapies, we reviewed relevant articles (and bibliographies of those articles) published from 2000 to 2016. This state-of-the-art review provides a comprehensive update on the understanding of AF in the world today, contemporary therapeutic options, and directions of ongoing and future study. (C) 2016 Mayo Foundation for Medical Education and Research
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available